Michael Thomas Mark
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Bone health and treatments
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Occupational and environmental lung diseases
Papers in
-
- Lung Cancer Treatments and Mutations 14
- Blood properties and coagulation 7
- Occupational and environmental lung diseases 6
- Oncology 25
- Lung Cancer Research Studies 7
- Cancer Immunotherapy and Biomarkers 5
- Cancer Treatment and Pharmacology 5
- Co-authors
- Walter Hans Reinhart (8 shared papers)Roland B. Walter (6 shared papers)Roger von Moos (21 shared papers)Martin Früh (15 shared papers)Sacha I. Rothschild (12 shared papers)Patrizia Froesch (12 shared papers)Beat J. K. Thurlimann (6 shared papers)Dirk Klingbiel (4 shared papers)
- Journals
- Annals of Oncology (15 papers)Lung Cancer (6 papers)ESMO Open (4 papers)Journal of Thoracic Oncology (4 papers)Swiss Medical Weekly (3 papers)
- Partner nations
- SwitzerlandItalyGermany
In The Last Decade
Michael Thomas Mark
60 papers receiving 888 citations
Michael Thomas Mark's Hit Papers
Peers
Comparison fields: 5 of 72
- Oncology 368
- Pulmonary and Respiratory Medicine 417
- Critical Care and Intensive Care Medicine 26
- Cancer Research 76
- Microbiology 2
Countries citing papers authored by Michael Thomas Mark
This map shows the geographic impact of Michael Thomas Mark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Thomas Mark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Thomas Mark more than expected).
Fields of papers citing papers by Michael Thomas Mark
This network shows the impact of papers produced by Michael Thomas Mark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Thomas Mark. The network helps show where Michael Thomas Mark may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Thomas Mark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non–Small-Cell Lung Cancer—A Multicenter Single-Arm Phase II Trial Hit paper breakdown → | 2021 | 257 |
| 2 | 2016 | 58 | |
| 3 | 2020 | 44 | |
| 4 | 2005 | 41 | |
| 5 | 2013 | 35 | |
| 6 | 2001 | 30 | |
| 7 | 2017 | 30 | |
| 8 | 2020 | 29 | |
| 9 | 2019 | 29 | |
| 10 | 2020 | 28 | |
| 11 | 2016 | 19 | |
| 12 | 2022 | 18 | |
| 13 | 2018 | 18 | |
| 14 | 2016 | 16 | |
| 15 | 2021 | 16 | |
| 16 | 2020 | 15 | |
| 17 | 2022 | 15 | |
| 18 | 2023 | 14 | |
| 19 | 1999 | 13 | |
| 20 | 2020 | 12 |
About Michael Thomas Mark
Michael Thomas Mark is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Physiology, Critical Care and Intensive Care Medicine and Cell Biology, having authored 63 papers that have together received 902 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Research Studies (7 papers), Blood properties and coagulation (7 papers), Occupational and environmental lung diseases (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer Treatment and Pharmacology (5 papers), Erythrocyte Function and Pathophysiology (5 papers) and Management of metastatic bone disease (4 papers). The work is most often cited by research in Oncology (368 citations), Pulmonary and Respiratory Medicine (417 citations), Critical Care and Intensive Care Medicine (26 citations), Cancer Research (76 citations) and Microbiology (2 citations). Michael Thomas Mark has collaborated with scholars based in Switzerland, Italy and Germany. Frequent co-authors include Walter Hans Reinhart, Roland B. Walter, Roger von Moos, Martin Früh, Sacha I. Rothschild, Patrizia Froesch, Beat J. K. Thurlimann, Dirk Klingbiel, Sabine P. Schmid and Richard L. Cathomas. Their work appears in journals such as Annals of Oncology, Lung Cancer, ESMO Open, Journal of Thoracic Oncology and Swiss Medical Weekly.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.